WallStSmart
NBP

NovaBridge Biosciences

NASDAQ: NBP · HEALTHCARE · BIOTECHNOLOGY

$2.35
-1.67% today

Updated 2026-04-29

Market cap
$271.77M
P/E ratio
P/S ratio
25.39x
EPS (TTM)
$-0.48
Dividend yield
52W range
$1 – $7
Volume
0.9M

NovaBridge Biosciences (NBP) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-59.4%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-570.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+1.4%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+7.8%
2025-12-31
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-04-08$-0.27$2.48$2.43-2.0%
2025-12-31$-0.31-287.5%$3.96$4.27+7.8%
2025-11-13$-0.06-20.0%$4.22$4.15-1.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.27
2025-12-31$-0.08$-0.31-287.5%
2025-09-30$-0.05$-0.06-20.0%
2025-06-30$-0.12$-0.07+41.7%
2025-03-31$-0.07$-0.04+42.9%
2024-12-31$-0.05$-0.06-20.0%
2020-12-31$2.19
2020-09-30$0.03

Frequently asked questions

Has NovaBridge Biosciences beaten earnings estimates?
NovaBridge Biosciences has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -59.4% over the last 3 quarters.
How does NBP stock react to earnings?
NBP stock has moved an average of +1.4% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.